Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
- PMID: 2300087
- DOI: 10.1056/NEJM199002083220602
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
Abstract
Twelve hundred ninety-six patients with resected colon cancer that either was locally invasive (Stage B2) or had regional nodal involvement (Stage C) were randomly assigned to observation or to treatment for one year with levamisole combined with fluorouracil. Patients with Stage C disease could also be randomly assigned to treatment with levamisole alone. The median follow-up time at this writing is 3 years (range, 2 to 5 1/2). Among the patients with Stage C disease, therapy with levamisole plus fluorouracil reduced the risk of cancer recurrence by 41 percent (P less than 0.0001). The overall death rate was reduced by 33 percent (P approximately 0.006). Treatment with levamisole alone had no detectable effect. The results in the patients with Stage B2 disease were equivocal and too preliminary to allow firm conclusions. Toxic effects of levamisole alone were infrequent, usually consisting of mild nausea with occasional dermatitis or leukopenia, and those of levamisole plus fluorouracil were essentially the same as those of fluorouracil alone--i.e., nausea, vomiting, stomatitis, diarrhea, dermatitis, and leukopenia. These reactions were usually not severe and did not greatly impede patients' compliance with their regimen. We conclude that adjuvant therapy with levamisole and fluorouracil should be standard treatment for Stage C colon carcinoma. Since most patients in our study were treated by community oncologists, this approach should be readily adaptable to conventional medical practice.
Comment in
-
Does adjuvant therapy work in colon cancer?N Engl J Med. 1990 Feb 8;322(6):399-401. doi: 10.1056/NEJM199002083220610. N Engl J Med. 1990. PMID: 2300092 No abstract available.
-
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.N Engl J Med. 1990 Jul 19;323(3):197-8. doi: 10.1056/NEJM199007193230312. N Engl J Med. 1990. PMID: 2362611 No abstract available.
Similar articles
-
Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.Br J Cancer. 1998 Apr;77(8):1349-54. doi: 10.1038/bjc.1998.225. Br J Cancer. 1998. PMID: 9579845 Free PMC article. Clinical Trial.
-
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report.Ann Intern Med. 1995 Mar 1;122(5):321-6. doi: 10.7326/0003-4819-122-5-199503010-00001. Ann Intern Med. 1995. PMID: 7847642 Clinical Trial.
-
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.J Clin Oncol. 1995 Dec;13(12):2936-43. doi: 10.1200/JCO.1995.13.12.2936. J Clin Oncol. 1995. PMID: 8523058 Clinical Trial.
-
Adjuvant treatment of node-positive colon carcinoma with levamisole and 5-fluorouracil.Oncology (Williston Park). 1991 Mar;5(3):63-70, 73; discussion 73-4. Oncology (Williston Park). 1991. PMID: 1829947 Review.
-
A systematic overview of chemotherapy effects in colorectal cancer.Acta Oncol. 2001;40(2-3):282-308. doi: 10.1080/02841860151116367. Acta Oncol. 2001. PMID: 11441937 Review.
Cited by
-
Adjuvant Chemotherapy and Tumor Sidedness in Stage II Colon Cancer: Analysis of the National Cancer Data Base.Front Oncol. 2020 Sep 15;10:568417. doi: 10.3389/fonc.2020.568417. eCollection 2020. Front Oncol. 2020. PMID: 33042845 Free PMC article.
-
Retrospective analysis of the effect of CAPOX and mFOLFOX6 dose intensity on survival in colorectal patients in the adjuvant setting.Curr Oncol. 2016 Jun;23(3):171-7. doi: 10.3747/co.23.3059. Epub 2016 Jun 9. Curr Oncol. 2016. PMID: 27330345 Free PMC article.
-
Sentinel lymph node biopsy as a prognostic factor in non-metastatic colon cancer: a prospective study.Clin Transl Oncol. 2017 Apr;19(4):432-439. doi: 10.1007/s12094-016-1543-8. Epub 2016 Aug 19. Clin Transl Oncol. 2017. PMID: 27541595
-
Neoadjuvant therapy before surgical treatment.EJC Suppl. 2013 Sep;11(2):45-59. doi: 10.1016/j.ejcsup.2013.07.032. EJC Suppl. 2013. PMID: 26217113 Free PMC article. Review.
-
Synchronous Colorectal Cancer: Improving Accuracy of Detection and Analyzing Molecular Heterogeneity-The Main Keys for Optimal Approach.Diagnostics (Basel). 2021 Feb 15;11(2):314. doi: 10.3390/diagnostics11020314. Diagnostics (Basel). 2021. PMID: 33671994 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources